Syros Pharmaceuticals raised $40,000,000 on , from Aisling Capital, Casdin Capital, ....

Get alertedif Syros Pharmaceuticals gets funded!
Amount:$40,000,000
Company:
Investors:, , , , ,
Industry:Biotechnology
Country:
State:
City:
United States
Massachusetts
Cambridge
Key people:Gregg Beloff (CFO)
Doug Cole (Board of Directors)
Douglas Cole (Director)
Jorge Conde (CFO)
Mark Murcko (SAB member)
Robert Nelsen (Director)
Alex Rives (Co-Founder)
Phillip Sharp (Director)
Nancy Simonian (CEO, Director, Executive Officer)
Richard Young (Director)
Data sources:
ow.ly - #clinicaltrials news Syros Pharmaceuticals Closes $40 Million Preferred Stock Financing https://t.co/FHNZmGkHmB
www.businesswire.com - Syros Pharmaceuticals Closes $40 Million Preferred Stock Financing | Business Wire
www.owler.com - Syros Pharmaceuticals received $40M in Equity Funding https://t.co/I5GhddWLQA
www.fiercebiotech.com - Syros Pharmaceuticals Closes $40 Million Preferred Stock Financing - FierceBiotech
Description:
Syros Pharmaceuticals, a Biotechnology-specialized company based in Watertown, United States, has raised 40M in an investment round. The date of the investment is 2016, January 13th.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!